From 05–07 March 2026, the joint IGLD–INSTAND Annual Symposium returns to Frankfurt—bringing together lab medicine, flow cytometry, stem cell and EV communities under one roof at Kap Europa (Messe Frankfurt).
PELOBiotech will be onsite at the industry exhibition (booth 10) to discuss animal-free / chemically defined media, primary & iPSC workflows, and practical paths to reproducibility and scalability for sensitive cell systems.
You can meet:
- Peter Frost (CEO)
- Anne Osmann (Marketing)
- Ingrid Kautner (Sales, Germany N/W) and also
Severin Mühleder (joining via our partner Bartelt GmbH, Graz)
If you’re attending and want an efficient technical discussion, bring:
- Your cell type / model (primary vs iPSC; 2D vs 3D)
Your critical assay readouts (viability, phenotype stability, activation markers, secretome/EV endpoints)
- Your constraints (xeno-free needs, lot-to-lot control, downstream compatibility)If you’re attending and want an efficient technical discussion, bring:
- Your cell type / model (primary vs iPSC; 2D vs 3D)
- Your challenges (xeno-free needs, lot-to-lot control, compatibility). If you’ll be at IGLD 2026, stop by booth 10
